C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/86 (2006.01) C12N 5/10 (2006.01) C12N 15/85 (2006.01) C12N 15/867 (2006.01) C12N 15/87 (2006.01)
Patent
CA 2168202
The present invention pertains to a method for efficiently introducing exogenous genes into primary lymphoid cells without drug selection which comprises the steps (a) deriving a retroviral vector and a helper cell combination that will yield a level of virus production in the range from 5 x 106 to 5 x 107 units/ml by transfecting a vector into a helper cell followed by selection, isolation of cell clones, and determination of viral titers to identify which virus-producing cell lines produce a virus titer in the range from 5 x 106 to 5 x 107 units/ml; (b) isolating a lymphoid cell subpopulation which can repopulate a specific lymphoid lineage or is a long-lived population by treating a suspension of lymphoid cells with a monoclonal antibody which removes undesired lymphoid cells to obtain an enriched lymphoid subpopulation; (c) culturing the enriched lymphoid subpopulation from step (b) with growth factors specific to the lymphoid subpopulation; (d) co-cultivating the lymphoid subpopulation from step (c) with a lawn of irradiated virus-producing cell line from step (a) to produce an infected lymphoid subpopulation; and (e) harvesting the infected lymphoid subpopulation. The invention further relates to a population of transfected lymphocytes, in whihch greater than about 90 % of the lymphocytes contain a provirus.
Dougherty Joseph
Kuo Ming-Ling
Sutkowski Natalie
Yacov Ron
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
University Of Medicine & Dentistry Of New Jersey
LandOfFree
Efficient gene transfer into primary lymphocytes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Efficient gene transfer into primary lymphocytes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Efficient gene transfer into primary lymphocytes will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1631454